NDC 70436-151

Arformoterol Tartrate Inhalation

Arformoterol Tartrate Inhalation

Arformoterol Tartrate Inhalation is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is Arformoterol Tartrate.

Product ID70436-151_27a1ba65-5029-462a-8e6e-5ac1056e6c72
NDC70436-151
Product TypeHuman Prescription Drug
Proprietary NameArformoterol Tartrate Inhalation
Generic NameArformoterol Tartrate Inhalation
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2021-06-22
Marketing CategoryANDA /
Application NumberANDA213762
Labeler NameSlate Run Pharmaceuticals
Substance NameARFORMOTEROL TARTRATE
Active Ingredient Strength15 ug/2mL
Pharm ClassesAdrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70436-151-57

30 POUCH in 1 CARTON (70436-151-57) > 1 VIAL in 1 POUCH (70436-151-19) > 2 mL in 1 VIAL
Marketing Start Date2021-06-22
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.